Prestige Brand Holdings Inc

Prestige Brand Holdings Inc

PBH · NYSE · Healthcare / Drug Manufacturers - Specialty & Generic

46.19USD+0.87 (+1.92%)

Price History

Full chart

Market Stats

Previous Close45.32
Open45.69
Day Range45.23 – 46.41
52-Week Range42.62 – 71.07
Volume500.40K
Market Cap2.22B
P/E (TTM)13.15
Forward P/E10.55
EPS3.57
Dividend Yield0.00%
Beta0.33
50-Day Avg50.26
200-Day Avg55.93

About

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Ronald M. Lombardi CPA
  • Employees890
  • Headquarters660 White Plains Road, Tarrytown, NY, United States, 10591, USA
  • Websitehttps://www.prestigebrands.com

Leadership

  • Mr. Ronald M. Lombardi CPAChairman, President & CEO · b. 1964
  • Ms. Christine Sacco CPACFO & COO · b. 1976
  • Mr. William C. P'Pool J.D.Senior VP, General Counsel & Corporate Secretary · b. 1965
  • Mr. Adel MekhailExecutive Vice President of Marketing & Sales · b. 1961
  • Mr. Philip David Terpolilli C.F.A.Director of Investor Relations
  • Dean SiegalDirector of Communications
  • Mr. Jose Luis RosadoSenior Vice President of Quality & Regulatory Affairs

Financials

Income Statement

Currency: USD2001-03-312002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Revenue8.65M46.25M71.73M87.92M303.32M296.67M318.63M326.60M312.71M302.02M336.51M441.08M623.60M601.88M714.62M806.25M882.06M1.04B975.78M963.01M943.37M1.09B1.13B1.13B1.14B1.09B
Growth (%)-+434.41%+55.09%+22.56%+244.99%-2.19%+7.40%+2.50%-4.25%-3.42%+11.42%+31.08%+41.38%-3.48%+18.73%+12.82%+9.40%+18.04%-6.28%-1.31%-2.04%+15.21%+3.76%-0.21%+1.10%-4.31%
Cost of Revenue3.08M18.73M27.02M36.28M141.35M139.43M153.15M158.10M149.44M144.59M165.63M213.70M276.38M261.83M308.40M339.04M381.77M464.67M420.20M410.79M395.89M466.17M502.43M500.91M503.30M514.07M
Gross Profit5.58M27.52M44.72M51.64M161.97M157.24M165.49M168.51M163.27M157.44M170.88M227.38M347.22M340.05M406.22M467.21M500.29M576.50M555.58M552.22M547.47M620.65M625.29M624.45M634.46M574.64M
Gross Margin64.47%59.49%62.34%58.74%53.40%53.00%51.94%51.59%52.21%52.13%50.78%51.55%55.68%56.50%56.84%57.95%56.72%55.37%56.94%57.34%58.03%57.11%55.45%55.49%55.76%52.78%
Operating Expense709.00K12.57M17.35M34.84M68.40M73.33M70.81M77.09M330.80M78.73M94.73M124.56M155.33M151.44M198.66M206.90M294.67M360.64M488.07M261.07M250.07M290.73M647.71M282.02M297.69M265.23M
Operating Income4.87M14.95M27.37M16.80M93.57M83.90M94.68M91.41M-167.53M78.70M76.14M102.82M191.88M188.62M207.56M260.31M205.61M215.87M67.50M291.15M297.40M329.92M-22.41M342.43M336.77M309.41M
Operating Margin56.28%32.32%38.15%19.11%30.85%28.28%29.71%27.99%-53.57%26.06%22.63%23.31%30.77%31.34%29.04%32.29%23.31%20.73%6.92%30.23%31.53%30.36%-1.99%30.43%29.60%28.42%
EBITDA4.87M18.94M32.64M22.23M103.11M83.90M94.68M105.44M-156.16M84.63M85.95M113.23M203.69M183.88M226.52M266.18M304.45M355.72M98.81M325.50M316.61M358.84M7.87M373.86M361.99M331.11M
EBITDA Margin56.28%40.95%45.50%25.29%33.99%28.28%29.71%32.28%-49.94%28.02%25.54%25.67%32.66%30.55%31.70%33.02%34.52%34.17%10.13%33.80%33.56%33.02%0.70%33.22%31.82%30.41%
Net Income2.53M545.00K-14.90M4.18M13.46M26.28M36.08M33.92M-186.78M32.12M29.22M37.21M65.50M72.61M78.26M99.91M69.39M339.57M-35.80M142.28M164.68M205.38M-82.31M209.34M214.60M190.30M
Net Income Margin29.21%1.18%-20.77%4.76%4.44%8.86%11.32%10.39%-59.73%10.63%8.68%8.44%10.50%12.06%10.95%12.39%7.87%32.61%-3.67%14.77%17.46%18.90%-7.30%18.60%18.86%17.48%
R&D-----------0000000--------
R&D as % of Total Revenue-----------0.00%0.00%0.00%0.00%0.00%0.00%0.00%--------
Interest Expense000045.10M36.91M40.48M38.07M28.58M22.94M27.32M41.34M84.42M68.64M81.33M85.32M93.55M106.27M105.30M96.57M82.33M64.29M69.16M67.16M47.63M42.34M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%14.87%12.44%12.70%11.66%9.14%7.59%8.12%9.37%13.54%11.40%11.38%10.58%10.61%10.21%10.79%10.03%8.73%5.92%6.13%5.97%4.19%3.89%

Balance Sheet

Currency: USD2001-03-312002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Total Assets151.29M174.04M142.06M326.62M1.00B1.04B1.06B1.05B801.38M791.41M1.06B1.76B1.74B1.80B2.67B2.95B3.91B3.76B3.44B3.51B3.43B3.67B3.35B3.32B3.40B3.55B
Total Liabilities105.26M115.30M98.20M200.11M615.29M629.24M618.08M570.08M507.00M462.35M695.09M1.36B1.26B1.23B2.04B2.20B3.09B2.58B2.35B2.34B2.07B2.09B1.91B1.66B1.57B1.66B
Total Equity46.03M58.74M43.86M126.51M385.85M409.41M445.33M479.07M294.38M329.06M361.83M402.73M477.94M563.36M627.62M744.34M822.55M1.18B1.10B1.17B1.36B1.58B1.45B1.66B1.83B1.89B
Cash-7.88M3.53M3.39M5.33M8.20M13.76M6.08M35.18M41.10M13.33M19.02M15.67M28.33M21.32M27.23M41.85M32.55M27.53M94.76M32.30M27.18M58.49M46.47M97.88M63.87M
Total Debt---148.69M495.36M498.63M463.35M411.23M378.34M324.14M486.94M1.12B970.90M934.41M3.15B1.63B2.19B1.99B1.80B1.77B1.51B1.51B1.37B1.14B1.04B1.05B
Net Debt--7.88M-3.53M145.30M490.03M490.43M449.59M405.15M343.16M283.05M473.61M1.10B955.23M906.08M1.57B1.60B2.15B1.96B1.77B1.67B1.48B1.48B1.31B1.09B946.37M981.56M

Cash Flow

Currency: USD2001-03-312002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312026-03-31
Operating Cash Flow1.98M3.94M12.52M6.14M51.04M53.86M71.90M44.99M66.68M59.43M86.67M67.45M137.60M111.58M156.25M174.35M147.77M210.11M189.28M217.12M235.61M259.92M229.72M248.93M251.51M257.63M
Investing Cash Flow--4.41M-2.17M-167.45M-425.84M-54.16M-31.05M-537.00K-4.67M7.32M-275.68M-662.21M11.22M-57.98M-805.26M-222.97M-694.60M-11.56M55.43M-16.57M-22.24M-256.51M-11.58M-20.11M-17.45M-136.84M
Financing Cash Flow36.49M5.53M-14.71M163.34M376.74M3.17M-35.29M-52.13M-32.90M-60.83M161.25M600.43M-152.12M-41.15M643.26M54.04M561.86M-208.96M-249.33M-131.43M-279.42M-7.57M-185.85M-241.01M-182.07M-156.06M
Capital Expenditure095.00K421.00K618.00K365.00K23.17M540.00K521.00K481.00K673.00K655.00K606.00K10.27M2.76M6.10M3.57M2.98M12.53M10.48M14.56M22.24M9.64M7.78M9.55M8.22M11.18M
Free Cash Flow1.98M3.85M12.10M5.52M50.68M30.69M71.36M44.47M66.20M58.75M86.02M66.85M127.34M108.82M150.15M170.78M144.79M197.58M178.80M202.56M213.36M250.28M221.93M239.38M243.29M246.45M
Dividends Paid-----------00000002.93M1.32M2.85M4.12M----
FCF to OCF100.00%97.59%96.64%89.93%99.28%56.97%99.25%98.84%99.28%98.87%99.24%99.10%92.54%97.52%96.10%97.95%97.99%94.04%94.46%93.29%90.56%96.29%96.61%96.16%96.73%95.66%
Dividend Paid to FCF-----------0.00%0.00%0.00%0.00%0.00%0.00%0.00%1.64%0.65%1.34%1.65%----

Earnings

Report DateMay 9, 2005Jul 27, 2005Nov 15, 2005Feb 6, 2006May 16, 2006Jul 31, 2006Nov 1, 2006Feb 5, 2007May 9, 2007Aug 7, 2007Nov 8, 2007Feb 8, 2008May 15, 2008Aug 7, 2008Nov 6, 2008Feb 5, 2009May 14, 2009Aug 5, 2009Nov 5, 2009Feb 5, 2010May 13, 2010Aug 5, 2010Nov 4, 2010Feb 9, 2011May 12, 2011Aug 4, 2011Nov 9, 2011Feb 9, 2012May 17, 2012Aug 7, 2012Nov 1, 2012Feb 7, 2013May 16, 2013Aug 1, 2013Nov 7, 2013Feb 6, 2014May 15, 2014Aug 7, 2014Nov 6, 2014Feb 5, 2015May 14, 2015Aug 6, 2015Nov 5, 2015Feb 4, 2016May 12, 2016Aug 4, 2016Nov 3, 2016Feb 2, 2017May 11, 2017Aug 3, 2017Nov 2, 2017Feb 1, 2018May 10, 2018Aug 2, 2018Nov 1, 2018Feb 7, 2019May 9, 2019Aug 1, 2019Oct 31, 2019Feb 6, 2020May 7, 2020Aug 6, 2020Nov 5, 2020Feb 4, 2021May 6, 2021Aug 5, 2021Nov 4, 2021Feb 3, 2022May 5, 2022Aug 4, 2022Nov 3, 2022Feb 2, 2023May 4, 2023Aug 3, 2023Nov 2, 2023Feb 8, 2024May 14, 2024Aug 8, 2024Nov 7, 2024Feb 6, 2025May 8, 2025Aug 7, 2025Nov 6, 2025Feb 5, 2026May 13, 2026Aug 6, 2026Nov 5, 2026
EPS Estimate0.230.150.190.240.240.130.160.200.190.170.180.180.190.150.170.160.170.170.180.190.210.160.210.210.180.220.260.250.230.290.330.340.350.380.430.390.330.400.450.410.450.490.570.490.490.540.610.560.550.640.660.700.610.670.630.720.700.640.660.750.740.700.720.770.780.870.990.880.891.041.001.011.041.011.071.041.140.861.081.161.291.010.971.161.390.891.06
EPS Actual0.260.080.150.190.240.170.180.180.160.170.160.170.210.160.170.160.180.170.190.210.150.190.230.200.180.230.260.250.260.350.420.370.360.400.470.300.350.410.500.480.470.520.600.530.520.590.630.610.540.660.610.700.620.680.650.730.720.650.680.810.820.860.780.810.791.141.020.990.911.091.021.041.071.061.071.061.020.901.091.221.320.950.861.141.230.98-
Surprise13.04%-46.67%-21.05%-20.83%0.00%30.77%12.50%-10.00%-15.79%0.00%-11.11%-5.56%10.53%6.67%0.00%0.00%5.88%0.00%5.56%10.53%-28.57%18.75%9.52%-4.76%0.00%4.55%0.00%0.00%13.04%20.69%27.27%8.82%2.86%5.26%9.30%-23.08%6.06%2.50%11.11%17.07%4.44%6.12%5.26%8.16%6.12%9.26%3.28%8.93%-1.82%3.13%-7.58%0.00%1.64%1.49%3.17%1.39%2.86%1.56%3.03%8.00%10.81%22.86%8.33%5.19%1.28%31.03%3.03%12.50%2.25%4.81%2.00%2.97%2.88%4.95%0.00%1.92%-10.53%4.65%0.93%5.17%2.33%-5.94%-11.34%-1.72%-11.51%10.11%-
TimingAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-market

Key Statistics & Ratios

Market Cap2.22B
Enterprise Value4.24B
Trailing P/E13.15
Forward P/E10.55
PEG Ratio1.51
Price / Sales2.01
Price / Book1.18
EPS3.57
Book Value40.46
Revenue (TTM)1.10B
Gross Profit (TTM)605.18M
EBITDA325.37M
Profit Margin15.57%
Operating Margin20.83%
Return on Equity9.12%
Return on Assets4.58%
Shares Outstanding47.37M
Shares Float46.70M
Beta0.33
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 7 analystsTarget 67.80
  • Strong Buy
    3
  • Hold
    3
  • Sell
    1

Ownership Breakdown

Institutions
116.35%
Insiders
1.41%
Retail / Other
0.00%

Top Institutional Holders

  • BlackRock Inc
    7.39M15.60%
  • Ariel Investments, LLC
    4.87M10.28%
  • Vanguard Portfolio Management, LLC
    2.80M5.92%
  • Dimensional Fund Advisors, Inc.
    2.66M5.62%
  • Kayne Anderson Rudnick Investment Management LLC
    2.20M4.65%
  • Vanguard Capital Management, LLC
    2.09M4.42%
  • Brandes Investment Partners & Co
    2.05M4.33%
  • State Street Corp
    1.97M4.16%
  • Geode Capital Management, LLC
    1.46M3.08%
  • Morgan Stanley - Brokerage Accounts
    1.36M2.87%
  • Allspring Global Investments Holdings, LLC
    1.27M2.68%
  • Westwood Holdings Group Inc
    1.12M2.36%
  • Delaware Management Holdings Inc
    1.07M2.26%

Top Fund Holders

  • Vanguard High-Yield Corporate Inv
    3.69M7.80%
  • iShares Core S&P Small-Cap ETF
    2.89M6.09%
  • Undiscovered Managers Behavioral Val L
    1.85M3.91%
  • Ariel Fund Investor
    1.70M3.60%
  • Vanguard MStar Total Stk Mkt Idx Invest
    1.52M3.20%
  • iShares Russell 2000 ETF
    1.23M2.60%
  • Vanguard Small Cap Index
    1.09M2.30%

Dividends

20181×
0.47Sep 27, 2018
20131×
0.31Dec 27, 2013